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The Seoul Declaration: A Manifesto for Ethical Medical Technology 
Presented and signed during iSMIT 2018 at Grand Wakerhill  
Seoul, November 10, 2018 (Fig 1) 
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Intersection of Medicine, Humanity and Technology 
 
It is often held that technology itself is incapable of possessing moral or ethical qualities, 
since "technology" is merely tool making.1 But many clinicians and researchers believe that 
each piece of healthcare technology is endowed with affordances that can impact and 
challenge ethical values and commitments all the time. The technology’s “values” and 
artificial intelligence are embedded in the devices and implements by those that design them, 
and those that decide how it must be made, marketed and used. This is the heart of the moral 
challenges surrounding the use of medical devices, AI and information technology. 
 
We recognize that unsafe medical technology and avoidable patient harm represents a serious 
challenge to health care service delivery globally. The significant level of preventable human 
suffering, the considerable strain on health system finances, and the loss of trust by patients 
and society in health systems and in their governments is of great concern. The recent related 
reports around unsanctioned gene editing of embryos, biased AI data algorithms, and the 
Food and Drug Administration (FDA) and CE flawed certifications of devices often based on 
false or incomplete information provided by the vendors, raises many legitimate and ethical 
questions about medical device oversight systems. These reports extend from vaginal meshes 
to hip replacements to surgical endoscopes and more, make it seem that the oversight 
mechanisms are bent too far toward making it easier for industry rather than making 
protection of public health the primary goal.2,3  The International Consortium of Investigative 
Journalists reported that “Health authorities across the globe have failed to protect millions 
of patients from poorly tested implants that can damage organs, deliver errant shocks to the 
heart, rot bones and poison blood, spew overdoses of opioids and cause other needless 
harm.”4   
 
Sadly, technology companies don't police themselves nor learn in a systematic and adequate 
manner and often only do the minimum of what the legislation demands.  Recent reports 
suggest that the FDA granted medical device makers special "exemptions" creating a vast and 
hidden repository of reports on device-related injuries and malfunctions hidden from doctors 
and from public view.5 Since 2016, at least 1.1 million incidents have flowed into this internal 
"alternative summary reporting" repository including deaths, serious injury and malfunction 
reports for about 100 medical devices, many implanted in patients or used in countless 
surgeries including minimally invasive and robotic-assisted. The FDA has just alerted 
clinicians about an increasing number of medical device reports (MDRs) associated with the 
use of surgical staplers for internal use and implantable surgical staples reporting from 
41,000 individual MDRs including 366 deaths, more than 9000 serious injuries, and more 
than 32,000 malfunctions.6 These reports speak to a profound crisis of public confidence in 
how medical devices and AI technologies are regulated. 
 
New AI technologies and automation now entering health care as outlined in the MITAT AI 
special issue 2019 to raise questions about the downsides of all the automation, voice our 
concerns constructively, design more thoughtful technology assessments and experiments 
done under real world conditions, and demand more transparency about financial conflicts of 
interest and device failures during the development, marketing and post marketing 
surveillance periods. Patient safety isn’t just a matter of the technical risk, it is also about the 
public perception of risk. AI and widespread automation acceptance depends on the public 
trusting the industry and in some cases that requires us to be extra cautious. Ultimately, 
regulators and policy makers will force upon medicine a more rigid and onerous risk 
avoidance accountability if we don't appreciate and actively address the highly coupled 
intersection of medicine, humanity and technology. 
 
The goal of the Seoul Declaration: A Manifesto for Ethical Medical Technology is to be a 
clarion call for the ethical, research and policy issues that surround the development and 
implementation of new medical and AI technologies. We mean to not scare anyone from 
promoting and implementing new technologies based on sound human factors design that 
promotes patient safety and can improve service delivery systems, at all levels of health care 
and in all health care settings. We believe there is a global and urgent need for a robust public 
debate to address the trade-offs of automation vs safety and to drive home just how much 
clinicians, policy makers and patients need to be made more aware and have the right to 
know what's coming down the technological pipeline or already is in our hospitals and can 
potentially cause patient and staff harm. 
 
Our most challenging task will be to try to de-politicize as many of these discussions as 
possible so that we can truly address the scientific, safety, quality and reliability questions in a 
transparent and truthful manner. Of course, when it comes to implementing public policy or 
even suggesting that policy is the right way to approach an issue, politics creep right back in.  
 
We welcome and invite the insights and feedback from clinicians, professional societies and 
medical industry leaders about the Seoul Declaration (below), in building a stronger political 
sponsorship and discourse, and a momentum at the highest levels of government and the 
house of medicine to actively address the development and deployment of ethical and human-
friendly medical technologies globally. We need more public debate and scientific data about 
how to best address these tensions while increasing our public commitment to weeding out 
the reported rampant conflicts of interest in both drug and medical device approval, 
procurement and in physician remuneration. The medical device area can be particularly 
susceptible for paying physicians kickbacks for patient referrals and prescriptions for 
unnecessary equipment. 7 
The near regular reporting of stolen medical data has allowed the public to see how medical 
devices fueled by AI and information technology can impact society’s moral values. As this 
data gathering becomes more automated and ever-present, we must ask can we trust the 
manufacturers to provide safety oversight of their own device innovations? Who is in control 
of collecting this data and what is done with it once it has been collected and stored by 
hospitals and medical device companies? Questions are being raised about the patient’s right 
to know about the production, access, and control of patient and process information, and do 
we as a society have the ability and the correct balance of legal rights to more meaningfully 
construct, exert control and positive influence, while not hampering innovation in this multi 
billion-dollar industry. We are pressed to address these questions while adhering to the 
precept that “Ethics is knowing the difference between what you have a right to do and what 
is right to do.” 
 The Seoul Declaration: A Manifesto for Ethical Medical Technology 
The Seoul Declaration on ethical medical technology is founded on the policies 
articulated in the World Health Assembly resolution WHA55.18 (2002), which urged 
Member States to “pay the closest possible attention to the problem of patient safety 
and establish and strengthen science-based systems, necessary for improving patient 
safety and the quality of health care”. 
Seoul is capital of Korea where the national ideology has been to “benefit all mankind” 
and has followed cultural values and norms of harmony, balance, and moderation 
which are fundamental to Korean culture and prosperity for 10000 years.  
 
We welcome the vision and leadership of countries in building political sponsorship 
and momentum at the highest levels of government to address the development and 
deployment of ethical medical technologies globally as well as locally, adhering to the 
precept that “Ethics is knowing the difference between what you have a right to do and 
what is right to do.” 
 
We reaffirm our commitment to improving medical technology and patient safety in 
order to reduce all avoidable harm and the risk of harm to all patients and people 
during their interaction with providers and health care systems, whoever they are, 
wherever they live, and endorse the following Seoul Declaration, while: 
Recognizing that unsafe health care and avoidable patient harm represents a serious 
challenge to health care service delivery globally, including the significant level of 
preventable human suffering, the considerable strain on health system finances and 
the loss of trust in health systems and in governments; 
Recognizing that  the need to promote and implement new technologies based on 
human factors design ensuring highest level of  patient safety and  strictly adhering to 
ethical rules are fundamental requirements of all service delivery systems, at all levels 
of health care and in all health care settings; 
Recognizing that the latest advances in medical technology, however, are raising many 
questions relative to ethics. The revolutionary inventions and advancements in the 
field of medicine have sometimes meant that traditional medical ethics could not be 
followed.  
Recognizing that smart implants, automated robotics, artificial intelligence, 
autonomous devices represent an ongoing opportunity to expand and support ethical 
technical innovation; 
Recognizing that ethical technologies that promote patient safety are important 
components of health care delivery and newer technologies are essential to achieve 
Universal Health Coverage (UHC), and moving towards UN Sustainable Development 
Goals (SDGs); and that patient safety systems and practices need to be established in 
all countries as one of the critical health care standards for achieving UHC on a 
sustainable basis; 
Recognizing the roles that information and communication technology play, from data 
collection and surveillance to monitoring and notification, anticipating risks, improved 
service delivery and improved safety and quality; 
Recognizing the role of engaging and empowering patients and families in the design 
and implementation of medical technologies that help deliver safe and quality care and 
in all aspects in health care - policy development, organizational level, decision 
making, health literacy and self-care. 
We declare that we will: 
Pledge to support ethical medical technologies with the goal of  
“Primum non nocere“  
Enable health care institutions, both public and private, from the level of primary care 
through to referral level care, to implement changes in an ethical and transparent 
manner, in terms of conflict of interest in systems and practices to improve patient 
safety and human values  using new medical technologies, while contributing to 
achieving UHC and SDGs;  
Support collaborative, ethical and transparent biomedical design 
methodologies working with industry for global health concerns. 
Collaboration is essential for successful engineering of complex projects and the 
biomedical engineering field stands out for the need of multidisciplinary teams capable 
of systematically addressing the development of medical devices considering medical, 
social, economical, technical, safety and regulatory issues. 
Call on our governments to fund and support development of new 
technical standards and open-access e-infrastructures for global action. 
The development and employment of adequate data management strategies and of 
methodologies for improved information sharing is intimately connected to the 
construction of healthy, sustainable, creative, effective and efficient collaborative 
design environments. Developing user-friendly, versatile, stable and safe open-access 
e-infrastructures, for supporting these online interactions in the collaborative 
development of biomedical devices, and following FAIR (findable, accessible, 
interoperable and reusable) data principles as the right direction for achieving global 
action towards the democratization of medical technology. 
Strive for harmonization of medical devices directives and accessible 
standards. Construct a framework for enabling medical technologies to reach 
everyone and everywhere relies on the use of common design practices and on the 
fulfillment of broadly accepted regulations that must warrant patients’ safety and 
improving human values  that should allow for a compliant device to be 
commercialized and applied worldwide. Establish clinical follow up, post market 
surveillance and registries of the use of medical devices, if needed in addition to loco 
regional regulatory demands. 
Sign and assume the present manifesto, as a symbol of commitment and 
deep respect for future collaboration. We will pursue the aims highlighted in 
this document, supporting our partners, promoting collaboration with significant 
stakeholders (from patients, patients’ associations, medical professionals and 
biomedical engineers, to educators, policy makers, manufacturers and companies), 
working towards universally accessible, intrinsically safe and high-quality medical 
technologies and solving unforeseen issues with a balance between pragmatism and 
idealism (pedes in terra ad sidera visus).  
Figure I Declaration singed by the attendees of iSMIT 30th international 
conference, Seoul, South Korea. 9th November 2018 
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